Item 9 Valuation
| INLB Stock | USD 0.0001 0.00 0.00% |
Item 9 seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Item 9 Labs from evaluating the firm fundamentals such as Current Valuation of 52.06 M, return on equity of -0.42, and Return On Asset of -0.0721 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Item 9's price fluctuation is out of control at this time. Calculation of the real value of Item 9 Labs is based on 3 months time horizon. Increasing Item 9's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Item 9 is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Item Pink Sheet. However, Item 9's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.3E-5 | Hype 1.0E-4 | Naive 1.01E-4 |
The real value of Item Pink Sheet, also known as its intrinsic value, is the underlying worth of Item 9 Labs Company, which is reflected in its stock price. It is based on Item 9's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Item 9's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Item 9 Labs helps investors to forecast how Item pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Item 9 more accurately as focusing exclusively on Item 9's fundamentals will not take into account other important factors: Item 9 Total Value Analysis
Item 9 Labs is currently expected to have valuation of 52.06 M with market capitalization of 17.25 M, debt of 7.22 M, and cash on hands of 441.66 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Item 9 fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
52.06 M | 17.25 M | 7.22 M | 441.66 K |
Item 9 Investor Information
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Item 9 Labs recorded a loss per share of 0.18. The entity last dividend was issued on the 18th of October 2018. The firm had 1:20 split on the 18th of October 2018. Based on the key measurements obtained from Item 9's financial statements, Item 9 Labs is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Item 9 Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Item 9 has an asset utilization ratio of 19.64 percent. This suggests that the Company is making $0.2 for each dollar of assets. An increasing asset utilization means that Item 9 Labs is more efficient with each dollar of assets it utilizes for everyday operations.Item 9 Ownership Allocation
Item 9 Labs has a total of 100 Million outstanding shares. Item 9 secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Item 9 Profitability Analysis
The company reported the previous year's revenue of 21.76 M. Net Loss for the year was (31.14 M) with profit before overhead, payroll, taxes, and interest of 7.31 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Item 9's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Item 9 and how it compares across the competition.
About Item 9 Valuation
The pink sheet valuation mechanism determines Item 9's current worth on a weekly basis. Our valuation model uses a comparative analysis of Item 9. We calculate exposure to Item 9's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Item 9's related companies.Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.
8 Steps to conduct Item 9's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Item 9's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Item 9's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Item 9's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Item 9's revenue streams: Identify Item 9's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Item 9's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Item 9's growth potential: Evaluate Item 9's management, business model, and growth potential.
- Determine Item 9's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Item 9's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Item 9 Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 97.7 M | |
| Retained Earnings | -65 M |
Complementary Tools for Item Pink Sheet analysis
When running Item 9's price analysis, check to measure Item 9's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Item 9 is operating at the current time. Most of Item 9's value examination focuses on studying past and present price action to predict the probability of Item 9's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Item 9's price. Additionally, you may evaluate how the addition of Item 9 to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |